SOCS1 and systemic lupus erythematosus: A SOCS1 mimetic peptide alleviates SLE symptoms in MRL/lpr mice and significantly corrects their immune system by enhancing Foxp3 expression in Tregs and reducing abnormal T and B cell effects (73).